Dr. Hwang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1021 Morehead Medical Dr
Suite 6100
Charlotte, NC 28204Phone+1 980-442-6410Fax+1 980-442-6141- Is this information wrong?
Education & Training
- UPMC Medical EducationFellowship, Hematology and Medical Oncology, 1998 - 2001
- UPMC Medical EducationResidency, Internal Medicine, 1995 - 1998
- University of Pittsburgh School of MedicineClass of 1995
Certifications & Licensure
- NC State Medical License 2013 - 2024
- DC State Medical License 2001 - 2014
- MD State Medical License 2010 - 2014
- VA State Medical License 2001 - 2010
- PA State Medical License 1996 - 2002
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- An Open-Label Study of QD Oral Administration of Tivozanib (AV-951) in Subjects With Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2009 Jan 01
- A Phase 2 Study of Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Junction (GEJ) Cancer Start of enrollment: 2015 Jul 07
- A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies Start of enrollment: 2016 Feb 19
- Join now to see all
Publications & Presentations
PubMed
- 60 citationsA phase I study of intravenous artesunate in patients with advanced solid tumor malignancies.John F. Deeken, Hongkun Wang, Marion Hartley, Amrita K. Cheema, Brandon G. Smaglo
Cancer Chemotherapy and Pharmacology. 2018-02-01 - 20 citationsCirculating microRNA profile predicts disease progression in patients receiving second-line treatment of lapatinib and capecitabine for metastatic pancreatic cancer.Xuefei Tian, Narayan Shivapurkar, Zheng Wu, Jimmy J. Hwang, Michael J. Pishvaian
Oncology Letters. 2016-03-01 - 35 citationsPhase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancer.Zheng Wu, Andrew T. Gabrielson, Jimmy J. Hwang, Michael J. Pishvaian, Louis M. Weiner
Cancer Chemotherapy and Pharmacology. 2015-10-27
Authored Content
- ASCO GI: Updates in Rectal Cancer and the FIGHT StudyJanuary 2021
Press Mentions
- Early Discovery of Liver Disease Improves Chances to Cure Liver CancerOctober 21st, 2021
- ASCO GI: Updates in Rectal Cancer and the FIGHT StudyJanuary 25th, 2021
- I’ll Never Stop FightingAugust 22nd, 2019
- Join now to see all
Hospital Affiliations
- Atrium Health's Carolinas Medical CenterCharlotte, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: